Clinical Trials Sponsored by Kwang Dong Pharmaceutical co., ltd.

Total 4038 results

Boryung Pharmaceutical Co., Ltd

Completed

A Clinical Trial to Compare the Pharmacokinetics and Safety of "BR1016C" With "BR1016D" in Healthy Volunteers

Chronic Heart Failure

Korea, Republic of
Qilu Pharmaceutical Co., Ltd.

Completed

Evaluating the Efficacy and Safety of QL0911 in Chemotherapy- Induced Thrombocytopenia

Chemotherapy-induced Thrombocytopenia

China
Biotech Pharmaceutical Co., Ltd.

Terminated

Tolerability, Safety and Pharmacokinetic Study of Humanized Anti-CD6 Monoclonal Antibody Injection in Chinese Psoriasis

Psoriasis

China
Daewoong Pharmaceutical Co. LTD.

Completed

An Exploratory Clinical Trial to Evaluate and Compare Safety and Pharmacokinetic Characteristics After Administration of the DWJ1439, DWJ1464, DWC202108 or DWC202109 in Healthy Adult Volunteers

Healthy Subject

Korea, Democratic People's Republic of
Daewoong Pharmaceutical Co. LTD.

Completed

Assessment of Elemental Impurities Level After Multiple Administration of DWJ1230 or DWB2001 in Subjects With Functional Diarrhea or Irritable Bowel Syndrome With Predominant Diarrhea.

Diarrhea

Korea, Republic of
Samik Pharmaceutical Co. Ltd.

Completed

A Clinical Trial to Evaluate the Pharmacokinetics and Safety of SIPS-2209-1 in Healthy Korean Volunteers

Healthy

Korea, Republic of
Daewoong Pharmaceutical Co. LTD.

Active, not recruiting

Phase 1 Clinical Trial to Evaluate the Effect of DWP14012 on the Pharmacokinetics of DWC202201 in Healthy Subjects

Drug Drug Interaction

Korea, Republic of
Qilu Pharmaceutical Co., Ltd.

Active, not recruiting

A Study to Evaluate the Efficacy and Safety of QL1706 Injection in Patients With Solid Tumors

Advanced Solid Tumors

China
Daewoong Pharmaceutical Co. LTD.

Enrolling by invitation

Drug-drug Interactions Between DWC202211 and DWC202212 in Healthy Subjects (DWJ1610)

Drug-drug Interaction

Korea, Republic of
Daewoong Pharmaceutical Co. LTD.

Completed

Drug-drug Interactions Between DWP14012 and DWC202202 in Healthy Subjects

Drug Drug Interaction

Korea, Republic of
Otsuka Pharmaceutical Co., Ltd.

Active, not recruiting

Post-Marketing Surveillance Study of Nalmefene Hydrochloride Hydrate in Patients With Alcohol Dependence

Alcohol Dependence

Japan
Dongkook Pharmaceutical Co., Ltd.

Completed

Pharmacokinetics and Safety of AmBisome and DKF-5122

Invasive Fungal Infections | Neutropenic Fever

Korea, Republic of
IlDong Pharmaceutical Co Ltd

Completed

Study to Assess the Antiviral Activity and Safety Endpoints for the Treatment of Besifovir 150mg Compared to Tenofovir 300mg in Chronic Hepatitis B Patients Who Have Resistance to Nucleoside Analogues (HBV)

Chronic Hepatitis B

Korea, Republic of
Qilu Pharmaceutical Co., Ltd.

Completed

Single Dose Mass Balance Study With [14C]Iruplinalkib (WX-0593) In Healthy Male Volunteers

Healthy

China
Daewoong Pharmaceutical Co. LTD.

Completed

Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic Characteristics of DWP16001 Drug A and C

Healthy Volunteers

Korea, Republic of
Daewoong Pharmaceutical Co. LTD.

Completed

Safety and Pharmacokinetics Evaluation Study According to the Dose of Camostat Mesylate in Healthy Volunteers

Healthy

Korea, Republic of
Daewoong Pharmaceutical Co. LTD.

Completed

Efficacy and Safety of DWP450 in Subjects With Benign Masseteric Hypertrophy

Benign Masseteric Hypertrophy

Korea, Republic of
Daewoong Pharmaceutical Co. LTD.

Completed

The Efficacy and Safety of DWP16001 Compared to Placebo in the Treatment of Type 2 Diabetes Mellitus.

T2DM (Type 2 Diabetes Mellitus)

Korea, Republic of
Daewoong Pharmaceutical Co. LTD.

Completed

The Efficacy and Safety of DWP16001 in Combination With Metformin in Patients With Type 2 Diabetes. (ENHANCE-M)

T2DM (Type 2 Diabetes Mellitus)

Korea, Republic of
Taisho Pharmaceutical Co., Ltd.

Completed

A QT/QTc Evaluation Study of TS-142 in Healthy Adult Subjects

Healthy Subjects

Japan
Taisho Pharmaceutical Co., Ltd.

Completed

A Clinical Pharmacology Study of TS-142 in Patients With Obstructive Sleep Apnea Hypopnea.

Patients With Mild Obstructive Sleep Apnea Hypopnea

Japan
Taisho Pharmaceutical Co., Ltd.

Completed

Drug-drug Interaction Study With TS-142 in Healthy Adult Subjects (Concomitant Administration of Itraconazole)

Healthy Subjects

Japan
Taisho Pharmaceutical Co., Ltd.

Completed

A Study to Evaluate Next Day Effects of TS-142 on Driving Performance in Healthy Subjects

Healthy Subjects

Japan
Taisho Pharmaceutical Co., Ltd.

Completed

Mass Balance Study of TS-142 in Healthy Adult Subjects.

Healthy Male Subjects

Japan
Taisho Pharmaceutical Co., Ltd.

Completed

A Study to Evaluate the Safety and Efficacy of TS-091 in Patients With Narcolepsy

Narcolepsy

Japan, Korea, Republic of
Taisho Pharmaceutical Co., Ltd.

Completed

Clinical Pharmacology Study of TS-143 in Nondialysis and Hemodialysis Patients With Chronic Kidney Disease

Chronic Kidney Disease

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

A Phase 2 Trial of OPC-64005 for Major Depressive Disorder

Major Depressive Disorder

Japan
Taiho Pharmaceutical Co., Ltd.

Completed

Mass Balance Study of [14C] TAS-205 in Healthy Volunteers

Healthy Male Subjects

Japan
Qilu Pharmaceutical Co., Ltd.

Active, not recruiting

Safety and Efficacy Study of First-line Treatment With QL1706 Plus Chemotherapy With or Without Bevacizumab in Women With Recurrent, or Metastatic Cervical Cancer

Cervical Cancer

China
Taejoon Pharmaceutical Co., Ltd.

Completed

Evaluating HA 0.15% Compared With Cyclosporine 0.05%, and Efficacy of Combination Therapy in Dry Eye Disease Patients

Dry Eye | Dry Eye Syndromes

Korea, Republic of
Boryung Pharmaceutical Co., Ltd

Completed

A Clinical Trial to Compare the Pharmacokinetics and Bioequivalence of "BR2008" With "BR2008-1" in Healthy Volunteers

Hepatocellular Carcinoma

Korea, Republic of
Samjin Pharmaceutical Co., Ltd.

Completed

Clinical Study to Investigate the Efficacy and Safety of SJP002 Ophthalmic Solution in Patients With Dry Eye Syndrome.

Dry Eye Syndromes

Korea, Republic of
Daewoong Pharmaceutical Co. LTD.

Completed

The Efficacy Nad Safety of DWP16001 Compared to Active Drug in the Treatment of Type 2 Diabetes Mellitus

T2DM (Type 2 Diabetes Mellitus)

Korea, Republic of
Samjin Pharmaceutical Co., Ltd.

Completed

A Phase 1 Clinical Study to Investigate the Pharmacokinetics and Safety/Tolerability of SA001 in Healthy Male Volunteers

Healthy

Korea, Republic of
Biotech Pharmaceutical Co., Ltd.

Completed

Phase IIa Study of Nimotuzumab to Treat Colorectal Cancer

Colorectal Cancer

China
Daewon Pharmaceutical Co., Ltd.

Completed

A Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics of DW1809-T2

Osteoarthritis | Rheumatoid Arthritis | Back Pain | Acute Upper Respiratory Tract Infection

Korea, Republic of
Jeil Pharmaceutical Co., Ltd.

Completed

To Evaluate the Efficacy and Safety of JLP-2002 on Symptoms of Overactive Bladder

Overactive Bladder

Korea, Republic of
Otsuka Pharmaceutical Co., Ltd.

Completed

Brexpiprazole for the Long-term Treatment of Patients With Agitation Associated With Dementia of the Alzheimer's Type

Agitation Associated With Dementia of the Alzheimer's Type

Japan
Daewoong Pharmaceutical Co. LTD.

Completed

A Clinical Trial to Evaluate the Efficacy and Safety of Olmesartan/Amlodipine/Rosuvastatin Combination Treatment in Patients With Concomitant Hypertension and Hyperlipidemia

Hypertension | Hyperlipidemias

Korea, Republic of
Daewon Pharmaceutical Co., Ltd.

Completed

To Evaluate the Efficacy and Safety of DW1903 in Acute and Chronic Gastritis Patient

Gastritis Acute | Gastritis Chronic

Korea, Republic of
Daewon Pharmaceutical Co., Ltd.

Completed

Clinical Trial to Evaluate the Safety and Pharmacokinetic/Pharmacodynamic Characteristics of DW1903

Gastritis

Korea, Republic of
Otsuka Pharmaceutical Co., Ltd.

Completed

Long-term Trial of OPA-15406 Ointment in Adult and Pediatric Patients With Atopic Dermatitis

Atopic Dermatitis

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

A Safety Evaluation Trial of TEV-48125 Self-administered in Migraine Patients

Migraine

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

A Phase I, Open-Label Trial to Assess the Absorption, Metabolism, and Excretion of (14C)-OPC-61815 in Healthy Male Japanese Subjects

Healthy Adult Male

United Kingdom
Daewoong Pharmaceutical Co. LTD.

Completed

To Evaluate Drug-drug Interactions Between DWN12088 and Pirfenidone or Nintedanib in Healthy Volunteers

Idiopathic Pulmonary Fibrosis

Korea, Republic of
Otsuka Pharmaceutical Co., Ltd.

Completed

Safety Trial of OPC-61815 Injection in Patients With Congestive Heart Failure Who Have Difficulty With or Are Incapable of Oral Intake

Congestive Heart Failure

Japan
AnnJi Pharmaceutical Co., Ltd.

Completed

A Study to Investigate the Safety, Tolerability, Pharmacokinetics of ALZ002 DS in Healthy Volunteers

Healthy

Australia
Daewoong Pharmaceutical Co. LTD.

Completed

Pharmacokinetic Interaction Between DWP14012 and DWC202005 in Healthy Volunteers

Drug-drug Interaction

Australia
Otsuka Pharmaceutical Co., Ltd.

Completed

Efficacy and Safety Trial of OPC-61815 Injection Compared With Tolvaptan 15-mg Tablet in Patients With Congestive Heart Failure

Congestive Heart Failure

Japan
Dongkook Pharmaceutical Co., Ltd.

Completed

Safety and Pharmacokinetic Characteristics of DKF-313

Healthy | Benign Prostate Hyperplasia

Korea, Republic of

3

Subscribe